Marabese M - Search Results

1

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.

Imbimbo M, Vitali M, Fabbri A, Ottaviano M, Pasello G, Petrini I, Palmieri G, Berardi R, Zucali P, Ganzinelli M, Marabese M, Broggini M, Marino M, Trama A, Rulli E, Hollander L, Pruneri G, Torri V, Garassino MC. Imbimbo M, et al. Among authors: marabese m. Clin Lung Cancer. 2018 Sep;19(5):e811-e814. doi: 10.1016/j.cllc.2018.06.005. Epub 2018 Jul 3. Clin Lung Cancer. 2018. PMID: 30033090 Clinical Trial.

2

P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line.

Vikhanskaya F, Marchini S, Marabese M, Galliera E, Broggini M. Vikhanskaya F, et al. Among authors: marabese m. Cancer Res. 2001 Feb 1;61(3):935-8. Cancer Res. 2001. PMID: 11221886

3

p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.

Vikhanskaya F, Bani MR, Borsotti P, Ghilardi C, Ceruti R, Ghisleni G, Marabese M, Giavazzi R, Broggini M, Taraboletti G. Vikhanskaya F, et al. Among authors: marabese m. Oncogene. 2001 Nov 1;20(50):7293-300. doi: 10.1038/sj.onc.1204896. Oncogene. 2001. PMID: 11704858

4

DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.

Marabese M, Vikhanskaya F, Rainelli C, Sakai T, Broggini M. Marabese M, et al. Nucleic Acids Res. 2003 Nov 15;31(22):6624-32. doi: 10.1093/nar/gkg869. Nucleic Acids Res. 2003. PMID: 14602923 Free PMC article.

5

Effects of inducible overexpression of DNp73alpha on cancer cell growth and response to treatment in vitro and in vivo.

Marabese M, Marchini S, Sabatino MA, Polato F, Vikhanskaya F, Marrazzo E, Riccardi E, Scanziani E, Broggini M. Marabese M, et al. Cell Death Differ. 2005 Jul;12(7):805-14. doi: 10.1038/sj.cdd.4401622. Cell Death Differ. 2005. PMID: 15877106

6

p73: a chiaroscuro gene in cancer.

Marabese M, Vikhanskaya F, Broggini M. Marabese M, et al. Eur J Cancer. 2007 Jun;43(9):1361-72. doi: 10.1016/j.ejca.2007.01.042. Epub 2007 Apr 10. Eur J Cancer. 2007. PMID: 17428654 Review.

7

DeltaNp63 expression is associated with poor survival in ovarian cancer.

Marchini S, Marabese M, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Fruscio R, Lissoni AA, Broggini M. Marchini S, et al. Among authors: marabese m. Ann Oncol. 2008 Mar;19(3):501-7. doi: 10.1093/annonc/mdm519. Epub 2007 Nov 12. Ann Oncol. 2008. PMID: 17998283 Free article.

8

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.

Marabese M, Marchini S, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Signorelli M, Moll UM, Codegoni AM, Broggini M. Marabese M, et al. Eur J Cancer. 2008 Jan;44(1):131-41. doi: 10.1016/j.ejca.2007.10.011. Epub 2007 Nov 26. Eur J Cancer. 2008. PMID: 18039564 Free PMC article.

9

HtrA2 enhances the apoptotic functions of p73 on bax.

Marabese M, Mazzoletti M, Vikhanskaya F, Broggini M. Marabese M, et al. Cell Death Differ. 2008 May;15(5):849-58. doi: 10.1038/cdd.2008.7. Epub 2008 Feb 8. Cell Death Differ. 2008. PMID: 18259191

10

Role of cetuximab in the treatment of patients with NSCLC: are we throwing out the baby with the bath water?

Floriani I, Garassino MC, Broggini M, Veronese S, Marsoni S, Marabese M, Farina G, Scanni A. Floriani I, et al. Among authors: marabese m. J Clin Oncol. 2010 Sep 20;28(27):e467; author reply e468. doi: 10.1200/JCO.2010.28.5973. Epub 2010 Jun 28. J Clin Oncol. 2010. PMID: 20585086 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page